Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The CooperCOO +0.11%89 EV-to-OCF is 16.82 as of Jul. 27, 2026, which is 35% below its 10-year median of 25.85. GuruFocus rates COO with a GF Score™ of 89/100 and a GF Value™ of $101.40 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 852 Medical Devices & Instruments companies, The Cooper ranks worse than 71.95% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, The Cooper's Enterprise Value is $16,034 Mil.
The Cooper's Cash Flow from Operations for the trailing twelve months (TTM) ended in Apr. 2026 was $953 Mil. Therefore, The Cooper's EV-to-OCF for today is 16.82.
The historical rank and industry rank for The Cooper's EV-to-OCF or its related term are showing as below:
COO'
s EV-to-OCF Range Over the Past 10 Years
Min: 14.63 Med: 25.85 Max: 44.43
Current: 16.82
During the past 13 years, the highest EV-to-OCF of The Cooper was 44.43. The lowest was 14.63. And the median was 25.85.
COO's EV-to-OCF is ranked worse than 71.95% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 7.75
vs COO: 16.82
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
The Cooper's share price for today is $70.31.
The Cooper's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.180.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
The Cooper EV-to-OCF Related Terms
The Cooper EV-to-OCF Historical Data
* Premium members only.
The historical data trend for The Cooper's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, The Cooper's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cooper EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where The Cooper's EV-to-OCF falls into.
The Cooper's current Enterprise Value is $16,034 Mil.
The Cooper's Cash Flow from Operations for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $953 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Cooper (COO) has a EV-to-OCF of 16.82 as of Jul. 27, 2026. This is 35% below median its historical median of 25.85. Over the past decade, The Cooper's EV-to-OCF has ranged from 14.63 to 44.43. According to the industry distribution chart, The Cooper ranks #613 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 71.9%.
Is The Cooper's EV-to-OCF too high?
The Cooper's current EV-to-OCF of 16.82 is 35% below median its 10-year median of 25.85. Over the past 10 years, this metric has ranged from a low of 14.63 to a high of 44.43. The Medical Devices & Instruments industry median EV-to-OCF is 7.75. The Cooper's value of 16.82 is 117% above this industry median. Based on the distribution chart, The Cooper ranks #613 out of 852 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, The Cooper has a GF Score™ of 89/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cooper's EV-to-OCF compare to SOLV and ALGN?
According to the Medical Devices & Instruments industry distribution chart, The Cooper ranks #613 out of 852 companies for EV-to-OCF. This places The Cooper in the lower half of its industry. The industry median EV-to-OCF is 7.75. The Cooper's value of 16.82 is 117% above this benchmark. Historically, The Cooper's own EV-to-OCF has ranged from 14.63 to 44.43 over the past decade. While the company's 10-year median is 25.85 vs. the industry median of 7.75, The Cooper has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.75, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Cooper's current EV-to-OCF of 16.82 is 117% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Cooper's current EV-to-OCF is 16.82, which is 35% below median its own 10-year median of 25.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cooper stock overvalued right now?
Based on GuruFocus' analysis, The Cooper (COO) is currently considered Significantly Undervalued. The stock's GF Value™ is $101.40, compared to a current price of $70.31 — trading 30.7% below its estimated fair value. The current EV-to-OCF is 16.82, which is 35% below median its 10-year median of 25.85 and 117% above the Medical Devices & Instruments industry median of 7.75. The Cooper's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For The Cooper (COO), the current EV-to-OCF is 16.82 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Cooper (COO) Overvalued in 2026?
Based on GuruFocus' analysis, The Cooper stock appears to be undervalued.
The current stock price of $70.31 is trading 30.7% below its estimated GF Value™ of $101.40.
GuruFocus considers The Cooper to be Significantly Undervalued.
Key valuation signals for COO:
EV-to-OCF: 16.82 (35% below median its 10-year median of 25.85)
GF Value™: $101.40 vs. price of $70.31 (30.7% below fair value)
Industry Position: 117% above the Medical Devices & Instruments median (#613 of 852)
No single metric tells the full story. See the COO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
89GF Score
Get the complete analysis for COO
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COO has been successfully added to your 
